Confirmed six-month disability progression rates over 4 years were similar in patients given the oral statin or a placebo in ...

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS 2024 Paris, 23 September 2024, 5.45pm CET AB Science SA (Euronext - ...

B.Riley Financial analyst William Wood has reiterated their bullish stance on IMUX stock, giving a Buy rating on September 16. William Wood ...

Sanofi Chief Executive Paul Hudson said on Monday that the company has not made a final decision yet on how it plans to split ...

Dr. Elizabeth Gromisch discusses her study, which showed the feasibility of a telehealth intervention for teaching ...

The meeting was part of the Authority’s strategy to strengthen partnerships with global pharmaceutical companies to provide ...

Gaps in access to care persist for US patients with MS and impact HRQOL to a large extent. Improving access to care for patients with MS should be prioritized.

including diseases like diabetes and multiple sclerosis (MS) that cause bladder nerve dysfunction, hormonal changes during ...

In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and ...

Patients with Parkinson’s disease (PD) suffer from a variety of movement disorders caused by a breakdown of brain neurons.

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, ...

In their lab, Hubbell and his colleagues simulated a multiple sclerosis-like disease ... we hope to be able to have treatments that are sort of one every six months, every year that could undo your ...